Bispebjerg Hospital | Dermatologisk Afdeling

Research site

(Unclaimed)

Location

Bispebjerg Bakke 23, Nielsine Nielsens Vej, opgang 9, Copenhagen, Hovedstaden, Denmark

Site insights

Top conditions

Top treatments

Dexamethasone

Ropivacaine

Rimegepant

Adalimumab

TD-9855

CP-690,550

Ustekinumab

somatropin

AGMB-129

Sepranolone

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 185 total trials

Cut Down on Carbohydrate in the Dietary Therapy of Type 2 Diabetes - The Meal Box Study (CutDM-MealBox)

The cornerstone in the initial treatment of type 2 diabetes (T2D) is lifestyle modification, involving-among other things-a healthy diet. However, sc...

Active, not recruiting

Diabetes Mellitus Type 2

Overweight and Obesity

Other: Carbohydrate-reduced high-protein (CRHP) Diet

Other: Conventional diabetes (CD) Diet

Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients

The objective is to compare the efficacy and safety of masitinib in combination with riluzole versus matched placebo in combination with riluzole for...

Enrolling

Amyotrophic Lateral Sclerosis

Drug: Placebo

Drug: Masitinib (4.5)

Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

This study is being conducted to evaluate the efficacy and tolerability of rimegepant in a population of adults that are unsuitable for triptan medic...

Enrolling

Migraine

Drug: Rimegepant

Drug: Placebo

Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications

This study is being conducted to evaluate the efficacy and tolerability of rimegepant for migraine prophylaxis in adults with a history of inadequate...

Enrolling

Migraine

Drug: Placebo

Drug: Rimegepant

Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy (CYPRESS)

This is a Phase 3, multi-center, randomized withdrawal study to evaluate the efficacy and durability of ampreloxetine in participants with MSA and sy...

Enrolling

MSA - Multiple System Atrophy

Symptomatic Neurogenic Orthostatic Hypotension

Drug: Ampreloxetine

Drug: Placebo

Phase I/IIa Trial to Evaluate AVX001 Gel in Doses of 1% or 3% Compared With Vehicle Over Four Weeks of Field-directed Treatment Period in Adult Subjects With AK (COAKS)

Actinic keratosis (AK), also known as solar keratosis, is a common skin condition characterised by abnormal growth of skin cells caused by long-term...

Active, not recruiting

Actinic Keratoses

Drug: AVX001

STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease

Many patients with Crohn's disease develop fibrotic narrowing (strictures) in their bowel, causing obstructive symptoms such as abdominal pain, cramp...

Enrolling

Fibrostenotic Crohn's Disease

Drug: AGMB-129

Drug: Placebo